a cure for hep c, aids, the flu and dengue..., page-70

No worries Donos and Chewy.

Chewy, if you are taking a stake, the FPOs trade in an inconsistent, gap filled manner, but seem to be drifting down on lack of interest, maybe you'll snag a bargain. Don't forget to have a look at the BITOs, they strike at the end of next year at 10c, they don't have the leverage they do when Chuck started this thread but they are still an interesting way to take a stake.

N_terra, I am hoping the capital will be raised on market, as the company has a history of proposing intelligent CRs that benefit existing shareholders. The risk to present holders is that BIT choose the somewhat easier option of a private placement to "sophisticated" (i.e parasitic) investors, though there is little justification for this as there will be significant market interest if the trials are a success.

The funding is unlikely to come from a major such a J&J (Michelle's ex-employer) as this would see Biotron in too vulnerable a position. These major pharmas will have their role to play in making the company, but it is unlikely to occur before the CR.


Cheers

Tawny